Exagen Inc. XGN Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Exagen Inc. in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The official record: Exagen Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Exagen Inc.'s shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Exagen Inc.'s shares (diluted)?
- Exagen Inc. (XGN) reported shares (diluted) of 23.9M in Q1 2026.
- How has Exagen Inc.'s shares (diluted) changed year-over-year?
- Exagen Inc.'s shares (diluted) increased by 28.5% year-over-year, from 18.6M to 23.9M.
- What is the long-term trend for Exagen Inc.'s shares (diluted)?
- Over 4 years (2021 to 2025), Exagen Inc.'s shares (diluted) has grown at a 7.6% compound annual growth rate (CAGR), from 62.8M to 84.1M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.